tiprankstipranks
Trending News
More News >
PuraPharm Corp. Ltd. (HK:1498)
:1498
Hong Kong Market

PuraPharm Corp. Ltd. (1498) Financial Statements

Compare
0 Followers

PuraPharm Corp. Ltd. Financial Overview

PuraPharm Corp. Ltd.'s market cap is currently HK$185.62M. The company's EPS TTM is HK$-0.089; its P/E ratio is ―; PuraPharm Corp. Ltd. is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueHK$ 382.09MHK$ 406.86MHK$ 448.07MHK$ 659.59MHK$ 601.82M
Gross ProfitHK$ 205.14MHK$ 216.63MHK$ 260.59MHK$ 421.85MHK$ 368.69M
Operating IncomeHK$ -29.41MHK$ -66.05MHK$ -64.50MHK$ 17.62MHK$ -4.88M
EBITDAHK$ 17.35MHK$ -26.17MHK$ -46.34MHK$ -40.03MHK$ 114.67M
Net IncomeHK$ -35.44MHK$ -106.08MHK$ -120.21MHK$ -121.88MHK$ 31.71M
Balance Sheet
Cash & Short-Term InvestmentsHK$ 12.79MHK$ 47.22MHK$ 107.01MHK$ 85.05MHK$ 126.46M
Total AssetsHK$ 715.73MHK$ 843.96MHK$ 1.02BHK$ 1.21BHK$ 1.37B
Total DebtHK$ 363.76MHK$ 424.77MHK$ 503.16MHK$ 531.96MHK$ 524.11M
Net DebtHK$ 350.96MHK$ 404.64MHK$ 396.14MHK$ 446.90MHK$ 397.65M
Total LiabilitiesHK$ 604.53MHK$ 690.73MHK$ 757.18MHK$ 803.13MHK$ 859.07M
Stockholders' EquityHK$ 111.20MHK$ 153.24MHK$ 258.29MHK$ 401.56MHK$ 511.66M
Cash Flow
Free Cash FlowHK$ 89.18MHK$ 57.95MHK$ 42.29MHK$ -45.89MHK$ 3.84M
Operating Cash FlowHK$ 103.98MHK$ 79.61MHK$ 65.85MHK$ -39.33MHK$ 86.68M
Investing Cash FlowHK$ -11.71MHK$ -18.20MHK$ -25.45MHK$ -3.67MHK$ -82.17M
Financing Cash FlowHK$ -86.43MHK$ -122.39MHK$ -12.94MHK$ 8.77MHK$ 29.56M
Currency in HKD

PuraPharm Corp. Ltd. Earnings and Revenue History

PuraPharm Corp. Ltd. Debt to Assets

PuraPharm Corp. Ltd. Cash Flow

PuraPharm Corp. Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis